Reza Mehrazin

Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity

Elizabeth R. Plimack, Jean Hoffman‐Censits, Rosalia Viterbo et al. · Journal of Clinical Oncology · 2014 · 281 citations · Full text

Medicine, Oncology, Urology +13

Survival outcomes after radical and partial nephrectomy for clinical <scp>T</scp> 2 renal tumours categorised by <scp>R</scp> . <scp>E</scp> . <scp>N</scp> . <scp>A</scp> . <scp>L</scp> . nephrometry score

Ryan Kopp, Reza Mehrazin, Kerrin Palazzi et al. · British Journal of Urology · 2013 · 139 citations

Medicine, Oncology, Surgery +17

Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy

John B. Malcolm, Aditya Bagrodia, Ithaar Derweesh et al. · British Journal of Urology · 2009 · 139 citations

Medicine, Nephrology, Oncology +13

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Matthew D. Galsky, Siamak Daneshmand, Sudeh Izadmehr et al. · Nature Medicine · 2023 · 133 citations · Full text

Medicine, Oncology, Urology +9

NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer

Bérengère Salomé, John P. Sfakianos, Daniel Ranti et al. · Cancer Cell · 2022 · 127 citations · Full text

Medicine, Immunology, Oncology +13